Equity Method Investment (Tables)

9 Months Ended

Sep. 30, 2022

Equity Method Investment

Schedule of financial information of Angel Pharmaceuticals Co.

		As of		As of
Balance Sheet Data (unaudited)	September 30, 2022		December 31, 2021
	(In thousands)
Current assets	$	30,879	$	38,608
Non-current assets		1,477		1,818
Current liabilities		3,236		2,119
Non-current liabilities		945		105
Stockholders' equity		28,175		38,202

	Three Months Ended				Nine Months Ended
	September 30,				September 30,
Statement of Operations Data (unaudited)	2022		2021		2022		2021
	(In thousands)
Net loss	$	(3,204)	$	(2,005)		(6,402)		(2,667)
Share of loss from investments accounted for using the equity method		(2,730)		(1,709)		(5,367)		(2,272)